| ²é¿´: 283 | »Ø¸´: 0 | |||
Paul-DingÌú³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
CTONG1002
|
| CTONG1002 ÐèҪȫÎÄ£¬¼±Çó£¬Ð»Ð»£¡A phase II trial of first-line nab-paclitaxel/carboplatin versus gemcitabine/carboplatin in advanced squamous cell carcinoma of the lung (CTONG1002). |
» ²ÂÄãϲ»¶
Õâ¸öÊǵ¥Ï¸°ûµ°°×ÖÊ×éѧÂï
ÒѾÓÐ0È˻ظ´
ÉúÃü¿ÆÑ§ºÍҽѧ¿ÆÑ§²¿ÃæÉÏ»ù½ðµÄ×ʽðÔ¤Ëã×ܶî
ÒѾÓÐ42È˻ظ´
¼ìÑéҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ227È˻ظ´













»Ø¸´´ËÂ¥